Profiel
Christopher Jordan worked as Vice President-Regulatory Affairs at Endocyte, Inc. from 2018 to 2019.
He completed his graduate degree at George Washington University and his undergraduate degree at Purdue University.
Eerdere bekende functies van Christopher Jordan
| Bedrijven | Functie | Einde |
|---|---|---|
| ENDOCYTE, INC. | Algemeen Adviseur | 01-12-2019 |
Opleiding van Christopher Jordan
| Purdue University | Undergraduate Degree |
| George Washington University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
